Related Experiment Video
Updated: Jul 5, 2026

08:51
Cerebellar Regional Dissection for Molecular Analysis
Published on: December 5, 2020
Brain structural damage in spinocerebellar ataxia type 1 : a VBM study
Andrea Ginestroni1, Riccardo Della Nave, Carlo Tessa
1Radiodiagnostic Section, Dept. of Clinical Physiopathology, University of Florence, Viale Morgagni 85, 50134, Florence, Italy.
Journal of Neurology
|April 29, 2008
Summary
Voxel-based morphometry reveals significant brain atrophy in spinocerebellar ataxia type 1 (SCA1), primarily in the cerebellum and brainstem. This structural damage correlates with disease duration and severity, suggesting VBM as a tool for monitoring SCA1 progression.
Area of Science:
- Neuroimaging
- Neurology
- Genetics
Background:
- Spinocerebellar ataxia type 1 (SCA1) neuropathology is poorly understood.
- Voxel-based morphometry (VBM) offers in vivo whole-brain analysis of gray matter (GM) and white matter (WM) volume.
- Previous studies have limited neuropathological descriptions of SCA1 brain structure.
Purpose of the Study:
- To quantitatively assess structural brain damage in genetically confirmed SCA1 patients using VBM.
- To investigate regional differences in GM and WM volume in SCA1.
- To correlate VBM findings with clinical disease parameters.
Main Methods:
- Fifteen SCA1 patients and 15 age-matched healthy controls underwent MRI.
- High-resolution T1-weighted images were acquired for VBM analysis.
- Clinical severity was assessed using the International Cerebellar Ataxia Rating Scale (ICARS) and Inherited Ataxia Clinical Rating Scale (IACRS).
Main Results:
- SCA1 patients exhibited significant, symmetric GM volume loss in the cerebellar vermis and anterior lobes compared to controls.
- WM volume was reduced in the peridentate region and middle cerebellar peduncles, but not the pons.
- Cerebellar and brainstem GM/WM volume loss correlated with disease duration and clinical scores (ICARS, IACRS).
Conclusions:
- VBM confirms predominant brainstem and cerebellar atrophy in SCA1.
- Structural changes identified by VBM correlate with clinical features of SCA1.
- VBM shows potential as a tool for monitoring SCA1 disease progression.
